Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes. Physicians & academics

November 17, 2023

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.

Møller AL, Thöni S, Keller F, Sharifli S, Rasmussen DGK, Genovese F, Karsdal MA, Mayer…

Christof Simon

Love0

Candidate composite biomarker to inform drug treatments for diabetic kidney disease. Physicians & academics

November 1, 2023

Candidate composite biomarker to inform drug treatments for diabetic kidney disease.

Jones RD, Abebe S, Distefano V, Mayer G, Poli I, Silvestri C, Slanzi D.Front Med…

Christof Simon

Love0

Physicians & academics

October 31, 2023

Urinary peptide analysis to predict the response to blood pressure medication

Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, Siwy J,…

Diana Derias

Love0

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study. Physicians & academics

September 14, 2023

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.

Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C,…

Christof Simon

Love0

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment. Physicians & academics

August 31, 2023

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment.

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thöni S, Mayer G, Mischak H, Vlahou…

Christof Simon

Love0

Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients Physicians & academics

June 6, 2023

Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thoeni S, Mayer G, Mischak H, Vlahou…

Christof Simon

Love0

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial. Physicians & academics

April 4, 2023

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial.

Curovic VR, Tofte N, Lindhardt M, Adamova K,  Bakker SJL, Beige J, Beulens JWJ, Birkenfeld…

Christof Simon

Love0

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Physicians & academics

December 31, 2022

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.

Denicolò S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G, Ju W, Perco…

Christof Simon

Love0

Biological variation and reference change value of the estimated glomerular filtration rate in humans: A systematic review and meta-analysis. Physicians & academics

October 6, 2022

Biological variation and reference change value of the estimated glomerular filtration rate in humans: A systematic review and meta-analysis.

 

Susanne

Love0

Clonal hematopoiesis of indeterminate potential and diabetic kidney disease: a nested case-control study. Physicians & academics

February 3, 2022

Clonal hematopoiesis of indeterminate potential and diabetic kidney disease: a nested case-control study.

Denicolò S, Vogi V, Keller F, Thöni S, Eder S, Heerspink HJL, Rosivall L, Wiecek…

Christof Simon

Love0

DC-ren associated study initiated. Physicians & academics

September 9, 2021

DC-ren associated study initiated.

First periodic report completed. DC-ren met major project milestones.

fein fein

Love0

Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review. Physicians & academics

September 9, 2021

Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review.

 

fein fein

Love0

Precision medicine approaches for diabetic kidney disease: opportunities and challenges. Physicians & academics

September 9, 2021

Precision medicine approaches for diabetic kidney disease: opportunities and challenges.

 

fein fein

Love0

Clustering longitudinal data on diabetic kidney disease. Physicians & academics

September 9, 2021

Clustering longitudinal data on diabetic kidney disease.

Mannone M, Distefano V, Silvestri C, Poli I. In CLADAG, eds. Porzio et al., Firenze…

Christof Simon

Love0

DC-ren project status For the public & patientsPhysicians & academics

September 2, 2021

DC-ren project status

First periodic report completed. DC-ren met major project milestones.

Susanne

Love0

Editorial: precision medicine in nephrology. Physicians & academics

June 22, 2021

Editorial: precision medicine in nephrology.

Mayer G. Nephrol Dial Transplant. 2021 Jun 22;36(Suppl 2):1-2. doi: 10.1093/ndt/gfaa366. In 2015, former US…

Christof Simon

Love0

Computer model aimed at optimising treatment of diabetic kidney diseases For the public & patients

April 9, 2020

Computer model aimed at optimising treatment of diabetic kidney diseases

Diabetic kidney diseases are the main cause of kidney failure in industrialised countries.

fein fein

Love0

Failure of biomarkers to personalize clinical practise in diabetic kidney disease. Are we asking the right questions? Physicians & academics

April 2, 2020

Failure of biomarkers to personalize clinical practise in diabetic kidney disease. Are we asking the right questions?

Failure of biomarkers to personalize clinical practise in diabetic kidney disease.

fein fein

Love0

European Union CORDIS fact sheet

https://cordis.europa.eu/project/id/848011